12:00 AM
Nov 12, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

SGX203 regulatory update

FDA granted Fast Track designation to Soligenix's SGX203 to treat mild-to-moderate pediatric Crohn's disease....

Read the full 49 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >